Urogen Pharma Ltd (URGN)

Cash & Equivalents

$79.13M

Quarterly · Period ending: · USD

URGN logo

URGN Cash & Equivalents

Latest reported$110.75M
URGN FY Cash & Equivalents ($3.04M → $110.75M)
High-resolution chart · PNG

URGN cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
110,745,000
171,987,000
95,002,000
55,408,000
44,360,000
52,864,000
49,688,000
101,318,000
36,999,000
21,362,000
17,975,000
3,870,000
3,037,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.